AACR logo

More articles from Psychosocial, Quality of Life, and Educational Aspects: Quality of Life - Supportive Care

Abstract P5-11-15: Rolapitant for the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients receiving multiple cycles of emetogenic chemotherapy
L Schwartzberg, R Navari, S Arora, D Powers, K Jordan, B Rapoport

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-15; DOI: 10.1158/1538-7445.SABCS16-P5-11-15
Abstract P5-11-04: Technology as a change agent for improving breast cancer quality care
A Hathaway, C Stricker, KI Halilova, KJ Hammelef, D Wujcik, WN Dudley, G Rocque

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-04; DOI: 10.1158/1538-7445.SABCS16-P5-11-04
Abstract P5-11-19: Sexual functioning among breast cancer survivors and their partners: A pilot study
I Makhoul, A Pennisi, D Ochoa, S Klimberg, R Henry-Tillman, K Mack, L Hutchins, AAC Sherman

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-19; DOI: 10.1158/1538-7445.SABCS16-P5-11-19
Abstract P5-11-16: Do patients and nurses outside clinical trial prefer subcutaneous trastuzumab over conventional intravenous infusion? Instituto Oncologico Nacional experience
O Castillo-Fernandez, A Cabreja, E Arauz, D Bellido, M Lim, R Lopez, L Montano

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-16; DOI: 10.1158/1538-7445.SABCS16-P5-11-16
Abstract P5-11-12: MOCHA: An institution-based care coordination app for post-hospitalization breast cancer patients
T He, R Ogunti, X Yu, M Puppala, S Chen, J Mancuso, W Stephen

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-12; DOI: 10.1158/1538-7445.SABCS16-P5-11-12
Abstract P5-11-03: Difference between 1^st and 2^nd generation serotonin receptor antagonists in triplet antiemetic therapy for highly emetogenic chemotherapy in breast cancer patients – according to recent multi-institutional double-blind randomized clinical research on the AC regimen
H Ogata, M Saito, M Tsuneizumi, G Kutomi, K Hosoya, Y Kawai, K Sugizaki, N Katsumata, K Senuma, T Kitabatake, M Suda, T Uomori, K Miura, M Kurata, Y Nitta, N Yonemoto, J Matsuoka

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-03; DOI: 10.1158/1538-7445.SABCS16-P5-11-03
Abstract P5-11-10: Evaluation of the relationship between psychological distress and risk for breast cancer
K Vennard, A Crocker, A Ogheneruona, M Cuke, M Wood

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-10; DOI: 10.1158/1538-7445.SABCS16-P5-11-10
Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
SB Goldfarb, J Konner, J Stevens, S Brouwer, NR Narain, R Ye, S Ravipaty, R Sarangarajan, VR Akmaev, JJ Jimenez, VR Belum, S 'Kitts, K Ciccolini, B Berman, ME Lacouture

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-11; DOI: 10.1158/1538-7445.SABCS16-P5-11-11
Abstract P5-11-18: Trajectory of patient (Pt) reported physical function (PF) during and after neoadjuvant chemotherapy in the I-SPY 2 trial
M Shah, R Jensen, C Yau, I Straehley, DA Berry, A DeMichele, MB Buxton, NM Hylton, J Perlmutter, WF Symmans, D Tripathy, D Yee, A Wallace, HG Kaplan, A Clark, AJ Chien, I-SPY 2 Investigators, LJ Esserman, ME Melisko

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-18; DOI: 10.1158/1538-7445.SABCS16-P5-11-18
Abstract P5-11-07: Pharmacokinetics of eflapegrastim in a phase 2 open-label dose-ranging study in breast cancer patients receiving TC regimen
JL Vacirca, Z Papai, Z Horvath, R Makharadze, G Reddy, T Song, P Koli, LS Schwartzberg

Cancer Research Feb 2017, 77 (4 Supplement) P5-11-07; DOI: 10.1158/1538-7445.SABCS16-P5-11-07

Main menu

User menu

Search

More articles from Psychosocial, Quality of Life, and Educational Aspects: Quality of Life - Supportive Care

Pages

Articles

Info for

About Cancer Research